The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)

Recruiting Observational Study
Alzheimer s Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 95
Sex
Any
Study type
Observational
Participants needed
220 (estimated)
Sponsor
University Hospital, Grenoble · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria : * Alzheimer's disease: * Age ≥ 50 years and older * Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011. * Score 18≤ MMSE ≤26 * Controls: * Age ≥ 50 years and older * MMSE score ≥ 26 For all subjects * …
Contacts

Sabrina Iannuzzi, Neuropsychologist

+334.76.76.57.90

siannuzzi@chu-grenoble.fr

CONTACT